180 Life Sciences EBITDA
Что обозначает EBITDA в 180 Life Sciences?
EBITDA 180 Life Sciences Corp. является -$16.63
Какое определение для EBITDA?
EBITDA - это прибыль компании до вычета процентов, налогов, обесценивания и амортизации, а также является бухгалтерской мерой, рассчитанной с использованием чистой прибыли компании до вычета процентных расходов, налогов, обесценивания и амортизации в качестве показателя текущей операционной прибыли компании.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA компаний в Health Care сектор на NASDAQ по сравнению с 180 Life Sciences
Что делает 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Компании с ebitda похож на 180 Life Sciences
- Siyata Mobile имеет EBITDA из -$16.69
- Galway Metals имеет EBITDA из -CAD$16.69
- Galway Metals имеет EBITDA из -CAD$16.69
- Amicus Therapeutics Inc имеет EBITDA из -$16.68
- Bionomics имеет EBITDA из -AUD$16.68
- Redx Pharma Plc имеет EBITDA из -£16.65
- 180 Life Sciences имеет EBITDA из -$16.63
- F-Secure Oyj имеет EBITDA из -€16.57
- Aleafia Health Inc имеет EBITDA из -CAD$16.57
- Clarus Corp имеет EBITDA из -$16.56
- Ioneer имеет EBITDA из -AUD$16.55
- Limeade имеет EBITDA из -$16.52
- American Resources имеет EBITDA из -$16.52